438 related articles for article (PubMed ID: 23967403)
1. Vascular permeability and drug delivery in cancers.
Azzi S; Hebda JK; Gavard J
Front Oncol; 2013; 3():211. PubMed ID: 23967403
[TBL] [Abstract][Full Text] [Related]
2. Jumping the barrier: VE-cadherin, VEGF and other angiogenic modifiers in cancer.
Le Guelte A; Dwyer J; Gavard J
Biol Cell; 2011 Dec; 103(12):593-605. PubMed ID: 22054419
[TBL] [Abstract][Full Text] [Related]
3. Normalization of the vasculature for treatment of cancer and other diseases.
Goel S; Duda DG; Xu L; Munn LL; Boucher Y; Fukumura D; Jain RK
Physiol Rev; 2011 Jul; 91(3):1071-121. PubMed ID: 21742796
[TBL] [Abstract][Full Text] [Related]
4. Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin.
Shen Y; Li S; Wang X; Wang M; Tian Q; Yang J; Wang J; Wang B; Liu P; Yang J
J Exp Clin Cancer Res; 2019 Oct; 38(1):427. PubMed ID: 31656203
[TBL] [Abstract][Full Text] [Related]
5. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
[TBL] [Abstract][Full Text] [Related]
6. Disorders of Vascular Permeability.
Park-Windhol C; D'Amore PA
Annu Rev Pathol; 2016 May; 11():251-81. PubMed ID: 26907525
[TBL] [Abstract][Full Text] [Related]
7. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin.
Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L
Elife; 2020 Apr; 9():. PubMed ID: 32312382
[TBL] [Abstract][Full Text] [Related]
8. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
Dvorak HF; Brown LF; Detmar M; Dvorak AM
Am J Pathol; 1995 May; 146(5):1029-39. PubMed ID: 7538264
[TBL] [Abstract][Full Text] [Related]
9. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.
Brown LF; Detmar M; Claffey K; Nagy JA; Feng D; Dvorak AM; Dvorak HF
EXS; 1997; 79():233-69. PubMed ID: 9002222
[TBL] [Abstract][Full Text] [Related]
10. Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism.
Baek YY; Lee DK; Kim J; Kim JH; Park W; Kim T; Han S; Jeoung D; You JC; Lee H; Won MH; Ha KS; Kwon YG; Kim YM
Oncotarget; 2017 Feb; 8(7):11763-11777. PubMed ID: 28052029
[TBL] [Abstract][Full Text] [Related]
11. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization.
Fukumura D; Jain RK
Microvasc Res; 2007; 74(2-3):72-84. PubMed ID: 17560615
[TBL] [Abstract][Full Text] [Related]
12. Tumor vascular endothelium: barrier or target in tumor directed drug delivery and immunotherapy.
Molema G; de Leij LF; Meijer DK
Pharm Res; 1997 Jan; 14(1):2-10. PubMed ID: 9034214
[TBL] [Abstract][Full Text] [Related]
13. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
Jain RK
Semin Oncol; 2002 Dec; 29(6 Suppl 16):3-9. PubMed ID: 12516032
[TBL] [Abstract][Full Text] [Related]
14. Trends and Challenges in Tumor Anti-Angiogenic Therapies.
Jászai J; Schmidt MHH
Cells; 2019 Sep; 8(9):. PubMed ID: 31540455
[TBL] [Abstract][Full Text] [Related]
15. Rap1 Small GTPase Regulates Vascular Endothelial-Cadherin-Mediated Endothelial Cell-Cell Junctions and Vascular Permeability.
Yamamoto K; Takagi Y; Ando K; Fukuhara S
Biol Pharm Bull; 2021; 44(10):1371-1379. PubMed ID: 34602545
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor-A
Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
[TBL] [Abstract][Full Text] [Related]
17. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle Delivery and Tumor Vascular Normalization: The Chicken or The Egg?
Mattheolabakis G; Mikelis CM
Front Oncol; 2019; 9():1227. PubMed ID: 31799190
[TBL] [Abstract][Full Text] [Related]
19. Flow shear stress regulates endothelial barrier function and expression of angiogenic factors in a 3D microfluidic tumor vascular model.
Buchanan CF; Verbridge SS; Vlachos PP; Rylander MN
Cell Adh Migr; 2014; 8(5):517-24. PubMed ID: 25482628
[TBL] [Abstract][Full Text] [Related]
20. Normalization of Tumor Vasculature by Oxygen Microbubbles with Ultrasound.
Ho YJ; Chu SW; Liao EC; Fan CH; Chan HL; Wei KC; Yeh CK
Theranostics; 2019; 9(24):7370-7383. PubMed ID: 31695774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
